Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 27/01/20121 min de lecture
Oral Dosage Form New Animal Drugs; Milbemycin Oxime, Lufenuron, and Praziquantel
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for the veterinary prescription use of milbemycin oxime, lufenuron, and praziquantel for the prevention of heartworm disease, for prevention and control of fleas, and for the treatment and control of various internal parasites in dogs.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →